107 related articles for article (PubMed ID: 29194371)
1. In Vivo Imaging of Prostate Cancer Tumors and Metastasis Using Non-Specific Fluorescent Nanoparticles in Mice.
Genevois C; Hocquelet A; Mazzocco C; Rustique E; Couillaud F; Grenier N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194371
[TBL] [Abstract][Full Text] [Related]
2. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
[TBL] [Abstract][Full Text] [Related]
3. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-Targeted Calcium Phosphosilicate Nanoparticles for Effective Imaging of Pancreatic and Prostate Cancer.
Abraham T; McGovern CO; Linton SS; Wilczynski Z; Adair JH; Matters GL
Int J Nanomedicine; 2021; 16():2297-2309. PubMed ID: 33776434
[TBL] [Abstract][Full Text] [Related]
6. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer.
Liu Y; Gunda V; Zhu X; Xu X; Wu J; Askhatova D; Farokhzad OC; Parangi S; Shi J
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7750-5. PubMed ID: 27342857
[TBL] [Abstract][Full Text] [Related]
7. Water-dispersible, pH-stable and highly-luminescent organic dye nanoparticles with amplified emissions for in vitro and in vivo bioimaging.
Yu J; Diao X; Zhang X; Chen X; Hao X; Li W; Zhang X; Lee CS
Small; 2014 Mar; 10(6):1125-32. PubMed ID: 24318966
[TBL] [Abstract][Full Text] [Related]
8. Development of an Activatable Fluorescent Probe for Prostate Cancer Imaging.
Yogo T; Umezawa K; Kamiya M; Hino R; Urano Y
Bioconjug Chem; 2017 Aug; 28(8):2069-2076. PubMed ID: 28691803
[TBL] [Abstract][Full Text] [Related]
9. Transplantable Animal Studies and Whole-Body Optical Imaging in Prostate Carcinoma.
van der Horst G; van der Mark M; Cheung H; van der Pluijm G
Methods Mol Biol; 2018; 1786():81-102. PubMed ID: 29786788
[TBL] [Abstract][Full Text] [Related]
10. Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location.
Perry JL; Reuter KG; Luft JC; Pecot CV; Zamboni W; DeSimone JM
Nano Lett; 2017 May; 17(5):2879-2886. PubMed ID: 28287740
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence and Bioluminescence Imaging of Orthotopic Brain Tumors in Mice.
McKinnon E; Moore A; Dixit S; Zhu Y; Broome AM
Methods Mol Biol; 2017; 1530():283-305. PubMed ID: 28150209
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent nanoparticle probes for imaging of cancer.
Santra S; Malhotra A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(5):501-510. PubMed ID: 21480546
[TBL] [Abstract][Full Text] [Related]
13. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
Abbasi AZ; Prasad P; Cai P; He C; Foltz WD; Amini MA; Gordijo CR; Rauth AM; Wu XY
J Control Release; 2015 Jul; 209():186-96. PubMed ID: 25908171
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
16. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
18. Small ultra-red fluorescent protein nanoparticles as exogenous probes for noninvasive tumor imaging in vivo.
An F; Chen N; Conlon WJ; Hachey JS; Xin J; Aras O; Rodriguez EA; Ting R
Int J Biol Macromol; 2020 Jun; 153():100-106. PubMed ID: 32105698
[TBL] [Abstract][Full Text] [Related]
19. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.
Na JH; Koo H; Lee S; Min KH; Park K; Yoo H; Lee SH; Park JH; Kwon IC; Jeong SY; Kim K
Biomaterials; 2011 Aug; 32(22):5252-61. PubMed ID: 21513975
[TBL] [Abstract][Full Text] [Related]
20. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
